ALMIRALL S.A. EO -,12 | 11.300 / -3.58% |
News
- Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
01/06/2021 / 14:00 - GlobeNewswire - Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group
01/04/2021 / 23:00 - GlobeNewswire - Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
12/15/2020 / 13:00 - GlobeNewswire - Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth
12/08/2020 / 14:13 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
12/01/2020 / 22:05 - GlobeNewswire - Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference
11/12/2020 / 22:01 - GlobeNewswire - Sientra Appoints Ron Menezes as President and Chief Executive Officer
11/09/2020 / 22:01 - GlobeNewswire - Paratek Pharmaceuticals Announces Third Quarter 2020 Total Revenue of $13.7 Million
11/05/2020 / 22:01 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
11/02/2020 / 22:05 - GlobeNewswire - Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020
10/27/2020 / 13:00 - GlobeNewswire - Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020
10/21/2020 / 14:00 - GlobeNewswire - Consortium of leading URW investors calls for REFOCUS, not RESET
10/15/2020 / 07:30 - GlobeNewswire - ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study
09/21/2020 / 12:00 - GlobeNewswire - Vectura Group plc - 2020 Interim Results
09/15/2020 / 13:00 - GlobeNewswire - ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
09/10/2020 / 09:08 - GlobeNewswire